The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: IG Design CEO Sells GBP528,000 In Shares

Thu, 10th Dec 2020 15:30

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

IG Design Group PLC - Milton Keynes, Bedfordshire-based consumer gift packaging - Chief Executive Officer Paul Fineman sells 87,304 shares via Howard Gary Fineman Intestacy Trust at 605.0 pence, worth GBP528,189, on Thursday. The trust continues to hold 87,304 shares, having sold half its holding.

----------

Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious diseases - Executive Chair Gabriele Cerrone buys 35,000 shares via Panetta Partners Ltd at 78p, worth GBP27,300, on Wednesday. Cerrone's interest remains about 34.1%.

----------

React Group PLC - South Derbyshire-based cleaning, hygiene and decontamination - Non-Executive Director Rob Gilbert buys 740,185 shares at 1.35p, worth GBP9,992, on Wednesday. Now has 6.0 million shares, a 0.2% stake. CEO Shaun Doak buys 150,000 at 1.33p, also on Wednesday. They are his only shares.

----------

Harworth Group PLC - Rotherham, South Yorkshire-based land and property regeneration - Non-Executive Director Patrick Bourke buys 40,000 shares at GBP1.05, worth GBP41,900, on Thursday. Bourke joined the board at the start of November. He is the former finance director of John Laing Group PLC, stepping down in 2019.

----------

Jaywing PLC - Sheffield, England-based data-driven media consultancy - CEO Andrew Fryatt buys 96,969 shares at 6.6p, worth GBP6,400, on Thursday. They are his only shares, having been appointed as CEO in March.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 May 2021 21:38

IN BRIEF: Tiziana Life Sciences annual loss widens

IN BRIEF: Tiziana Life Sciences annual loss widens

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
13 Apr 2021 21:56

TRADING UPDATES: Clipper Logistics, JD Sports ink letter of intent

TRADING UPDATES: Clipper Logistics, JD Sports ink letter of intent

Read more
30 Mar 2021 20:34

IN BRIEF: Tiziana plans phase II trials for nasal Covid-19 treatment

IN BRIEF: Tiziana plans phase II trials for nasal Covid-19 treatment

Read more
5 Feb 2021 12:28

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Read more
2 Feb 2021 11:35

Tiziana Surges As Nasal Therapy May Be Effective In New Virus Variants

Tiziana Surges As Nasal Therapy May Be Effective In New Virus Variants

Read more
27 Jan 2021 14:22

IN BRIEF: Tiziana Files US Statement Over USD250 Million Of Securities

IN BRIEF: Tiziana Files US Statement Over USD250 Million Of Securities

Read more
13 Jan 2021 16:21

UK EXECUTIVE CHANGE SUMMARY: Ex-Savills CEO To Be Tritax Big Box Chair

UK EXECUTIVE CHANGE SUMMARY: Ex-Savills CEO To Be Tritax Big Box Chair

Read more
7 Jan 2021 16:02

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

Read more
4 Jan 2021 15:19

Tiziana completes Covid-19 study in Brazil

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced the completion of its clinical study in Brazil on Monday, investigating nasally-administered Foralumab - its proprietary human monoclonal antibody - either alone or in combination with orally administered dexamethasone in Covid-19 patients.

Read more
4 Jan 2021 12:16

LONDON MARKET MIDDAY: Vaccine Rollouts, M&A And Gold Surge Boost FTSE

LONDON MARKET MIDDAY: Vaccine Rollouts, M&A And Gold Surge Boost FTSE

Read more
4 Jan 2021 12:15

Tiziana Announces Foralumab Trial Completion For Covid-19 Treatment

Tiziana Announces Foralumab Trial Completion For Covid-19 Treatment

Read more
4 Jan 2021 10:44

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

Read more
17 Dec 2020 19:37

UK TRADING UPDATE SUMMARY: Polar Capital Adds GBP1.2 Billion To Assets

UK TRADING UPDATE SUMMARY: Polar Capital Adds GBP1.2 Billion To Assets

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.